BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CRC for Asthma 

K-25 Medical Foundation Building
University of Sydney
Sydney  New South Wales  2006  Australia
Phone: 61-2-9036-3125 Fax: 61-2-9036-3129


SEARCH JOBS


The CRC for Asthma is a joint venture between two medical research institutes, three universities, two pharmaceutical companies and the New South Wales Department of Health. The key researchers are based in Sydney, Melbourne, Newcastle and Perth and collectively they are one of the strongest asthma research teams in the world.

There are 4 broad areas of research:

Immunomodulation & Allergy

Strategies which fully define critical allergens in the allergic immune response with resultant improved diagnostic tests, novel treatment regimens and assays to monitor clinical efficacy will cause a significant reduction in the burden of asthma. The aim of this project is to develop vaccines that down-regulate pathogenic allergen-specific Th2-type cytokine production and to establish a laboratory assay that reliably monitors immunotherapy efficacy.

Genomics

Defining the genetic and molecular basis of asthma will give insight into the pathophysiology of the condition and help us to understand why some people get asthma, why there are different asthma subtypes, why asthma severities vary and how genetics influences treatment responses.

Asthma Management & Prevention

This program endeavours to minimise the burden of long-term drug treatment and in some cases, substantial disability by:

  • studying the effectiveness of interventions in preventing asthma
  • undertaking trials to better target treatment
  • gaining an understanding of the attitudes of consumers and health professionals
  • assessing the economic burden on the individual and community
  • developing enhanced guidelines for health professionals

    Pathophysiology & Diagnosis

    The definition, diagnosis, assessment, treatment and monitoring of any condition is dependent on a clear understanding of the pathophysiology. The fact that there is still argument about even the definition of asthma is an indication that the pathophysiology is still unclear. The projects in this program are designed to provide a better understanding of the fundamental problem in asthma ie. airway obstruction.

    Last Updated: 04-27-04

     Key Statistics


    Email:
    Ownership: Private

    Web Site: CRC for Asthma
    Employees:
    Symbol: 
     









  •  Company News
    Currently No News Articles